4//SEC Filing
Saad Mark E 4
Accession 0000950170-25-027076
CIK 0001579428other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 7:59 PM ET
Size
5.3 KB
Accession
0000950170-25-027076
Insider Transaction Report
Form 4
Saad Mark E
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-02-21+1,494→ 1,494 totalExercise: $137.75From: 2025-02-21Exp: 2035-02-20→ Common Stock (1,494 underlying)
Footnotes (1)
- [F1]Represents 1,494 options elected to be received in lieu of cash compensation earned in 2024. All of such options are immediately exercisable.
Documents
Issuer
Axsome Therapeutics, Inc.
CIK 0001579428
Entity typeother
Related Parties
1- filerCIK 0001295913
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 7:59 PM ET
- Size
- 5.3 KB